Ko YG - Search Results

Year	Number of Results
1992	2
1995	3
1996	1
1998	1
1999	2
2000	8
2001	6
2002	8
2003	8
2004	14
2005	19
2006	25
2007	25
2008	24
2009	31
2010	46
2011	51
2012	62
2013	53
2014	50
2015	38
2016	45
2017	37
2018	44
2019	53
2020	68
2021	69
2022	59
2023	41
2024	40
2025	33

1

Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.

Hong SJ, Lee YJ, Lee SJ, Hong BK, Kang WC, Lee JY, Lee JB, Yang TH, Yoon J, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK; LODESTAR Investigators. Hong SJ, et al. Among authors: ko yg. JAMA. 2023 Apr 4;329(13):1078-1087. doi: 10.1001/jama.2023.2487. JAMA. 2023. PMID: 36877807 Free PMC article. Clinical Trial.

2

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial.

Kim BK, Hong SJ, Lee YJ, Hong SJ, Yun KH, Hong BK, Heo JH, Rha SW, Cho YH, Lee SJ, Ahn CM, Kim JS, Ko YG, Choi D, Jang Y, Hong MK; RACING investigators. Kim BK, et al. Among authors: ko yg. Lancet. 2022 Jul 30;400(10349):380-390. doi: 10.1016/S0140-6736(22)00916-3. Epub 2022 Jul 18. Lancet. 2022. PMID: 35863366 Clinical Trial.

3

Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.

Lee YJ, Hong SJ, Kang WC, Hong BK, Lee JY, Lee JB, Cho HJ, Yoon J, Lee SJ, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK; LODESTAR investigators. Lee YJ, et al. Among authors: ko yg. BMJ. 2023 Oct 18;383:e075837. doi: 10.1136/bmj-2023-075837. BMJ. 2023. PMID: 37852649 Free PMC article. Clinical Trial.

4

Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial.

Kim BK, Hong SJ, Cho YH, Yun KH, Kim YH, Suh Y, Cho JY, Her AY, Cho S, Jeon DW, Yoo SY, Cho DK, Hong BK, Kwon H, Ahn CM, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y; TICO Investigators. Kim BK, et al. Among authors: ko yg. JAMA. 2020 Jun 16;323(23):2407-2416. doi: 10.1001/jama.2020.7580. JAMA. 2020. PMID: 32543684 Free PMC article. Clinical Trial.

5

Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells.

Hwang HJ, Lee YR, Kang D, Lee HC, Seo HR, Ryu JK, Kim YN, Ko YG, Park HJ, Lee JS. Hwang HJ, et al. Among authors: ko yg. Cancer Lett. 2020 Oct 10;490:100-110. doi: 10.1016/j.canlet.2020.06.019. Epub 2020 Jul 11. Cancer Lett. 2020. PMID: 32659248

6

Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis.

Lee SH, Lee YJ, Heo JH, Hur SH, Choi HH, Kim KJ, Kim JH, Park KH, Lee JH, Choi YJ, Lee SJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Kim JS. Lee SH, et al. Among authors: ko yg. J Am Coll Cardiol. 2023 Apr 11;81(14):1339-1349. doi: 10.1016/j.jacc.2023.02.007. J Am Coll Cardiol. 2023. PMID: 37019580 Free article. Clinical Trial.

7

FLRT2 prevents endothelial cell senescence and vascular aging by regulating the ITGB4/mTORC2/p53 signaling pathway.

Hwang HJ, Kang D, Kim JR, Choi JH, Ryu JK, Herman AB, Ko YG, Park HJ, Gorospe M, Lee JS. Hwang HJ, et al. Among authors: ko yg. JCI Insight. 2024 Apr 8;9(7):e172678. doi: 10.1172/jci.insight.172678. JCI Insight. 2024. PMID: 38587072 Free PMC article.

8

Intravascular ultrasound-guided drug-coated balloon angioplasty for femoropopliteal artery disease: a clinical trial.

Ko YG, Lee SJ, Ahn CM, Lee SH, Lee YJ, Kim BK, Hong MK, Jang Y, Kim TH, Park HW, Jang JY, Lee JH, Park JH, Kim SH, Im E, Park SH, Choi D; IVUS-DCB investigators. Ko YG, et al. Eur Heart J. 2024 Aug 16;45(31):2839-2847. doi: 10.1093/eurheartj/ehae372. Eur Heart J. 2024. PMID: 38966936 Clinical Trial.

9

Alternative LDL Cholesterol-Lowering Strategy vs High-Intensity Statins in Atherosclerotic Cardiovascular Disease: A Systematic Review and Individual Patient Data Meta-Analysis.

Lee YJ, Hong BK, Yun KH, Kang WC, Hong SJ, Lee SH, Lee SJ, Hong SJ, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK. Lee YJ, et al. Among authors: ko yg. JAMA Cardiol. 2025 Feb 1;10(2):137-144. doi: 10.1001/jamacardio.2024.3911. JAMA Cardiol. 2025. PMID: 39565634 Free PMC article.

10

Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation.

Hwang HJ, Kang D, Shin J, Jung J, Ko S, Jung KH, Hong SS, Park JE, Oh MJ, An HJ, Yang WH, Ko YG, Cha JH, Lee JS. Hwang HJ, et al. Among authors: ko yg. Nat Commun. 2025 Jan 3;16(1):353. doi: 10.1038/s41467-024-54132-1. Nat Commun. 2025. PMID: 39753537 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

843 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

843 results

Results by year